數位生物製造市場:按類型、按應用、按地區 - 規模、份額、展望、機會分析,2022-2030 年
市場調查報告書
商品編碼
1149834

數位生物製造市場:按類型、按應用、按地區 - 規模、份額、展望、機會分析,2022-2030 年

Digital Biomanufacturing Market, by Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 243 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

數位生物製造被認為是數位生物技術的進一步發展。數位生物製造根據預期產品質量和批量盈利能力等關鍵因素實時優化流程。數位生物製造軟件提高了資產的可靠性和可用性並降低了維護成本。它還可以消除錯誤並提高效率。

數位生物製造的好處是:

  • 加強監控
  • 數據收集和處理
  • 連通性
  • 計算機能力
  • 過程控制算法
  • 自動化

市場動態

數位生物製造有助於提高現有流程和設施的生產力和穩健性。影響生物製造設施的一個關鍵問題可以通過使用新的數位技術來解決。因此,向智能製造的轉變和智能製造的引入正在推動市場的增長。通過數位化製造在價值鏈的各個層面實現快速周轉意味著降低維護成本。這正在推動市場的增長。數位技術支持的實時生產可視化為關鍵決策制定提供更好的信息並加速創新。因此,數位生物製造技術越來越多地用於整個製藥和生物製藥行業。製造商對數位生物製造的需求不斷增加,數位生物製造正在實施物聯網 (IoT)、人工智能 (AI) 等新技術來推動生產。此外,製造自動化將為克服商業成功所面臨的許多挑戰提供大量機會。這反過來又為不久的將來的市場增長創造了重要機會。

這項研究的主要特點

  • 本報告對全球數位生物製造市場進行了深入分析,提供了以 2021 年為基準年的預測期(2022-2030 年)的市場規模、複合年增長率 (CAGR%)。
  • 它揭示了不同細分市場的潛在收入機會,並描述了該市場具有吸引力的投資建議矩陣。
  • 它還提供了有關市場驅動因素、限制因素、機會、新藥發布和批准、區域前景以及主要參與者採用的競爭戰略的重要見解。
  • 它根據公司概況、業績、產品組合、地域分佈、分銷戰略、關鍵發展和戰略以及未來計劃等參數,介紹了全球數位生物製造市場的主要參與者。.
  • 本研究涵蓋的主要公司包括 3M、ABB、Cytiva、Siemens、immersciobio、Sanofi、BIOMERIEUX、Agilent Technologies, Inc、GE Healthcare、Culture Biosciences
  • 這份報告中的見解將使公司的營銷人員和管理人員能夠就未來的產品發布、技術升級、市場擴張和營銷策略做出明智的決策。.
  • 《全球數位生物製造市場》報告面向該行業的各種利益相關者,包括投資者、供應商、製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球數位生物製造市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第 2 章市場概述

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場細分:按類型
    • 市場細分:按應用
    • 按地區劃分的市場細分
  • 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

  • 市場動態
    • 司機
    • 約束因素
    • 市場機會
  • 影響分析
  • 主要發展狀況
  • 監管情景
  • 害蟲分析
  • 波特分析
  • 數位生物製造的進步
  • 數位生物製造概述

第 4 章全球數位生物製造市場:冠狀病毒 (COVID-19) 大流行的影響

  • 政府抗擊 COVID-19 的努力
  • COVID-19 的流行病學特徵
  • COVID-19 對供應鏈的影響

第 5 章全球數位生物製造市場:按類型,2017-2030

  • 製造技術
  • 分析和過程控制技術
  • 其他

第 6 章全球數位生物製造市場:按應用,2017-2030

  • 生物過程優化
  • 生物製造過程自動化和控制
  • 其他

第 7 章全球數位生物製造市場:按地區劃分,2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 東盟
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 中非
  • 北非

第八章競爭格局

  • 公司簡介
    • 3M
    • ABB
    • Cytiva
    • Siemens
    • immersciobio
    • Sanofi
    • BIOMERIEUX
    • Agilent Technologies, Inc
    • GE Healthcare
    • Culture Biosciences

第 9 章

  • 參考資料
  • 調查方法
簡介目錄
Product Code: CMI5282

Digital biomanufacturing is consider as a potentially greater manifestation of digital biotechnology. Digital biomanufacturing offers real-time process optimization based on extremely valued factors like expected product quality and batch profitability. Digital biomanufacturing software improves asset dependability and availability while lowering maintenance costs. It helps to increase efficiency by elimating the errors.

Advantages of digital manufacturing includes:

  • Increased Monitoring
  • Data Collection and Handling
  • Connectivity
  • Computer power
  • Process control algorithms
  • Automation

Market Dynamics

Digital biomanufacturing helps to improve productivity and robustness of existing processes and facilities. Key issues affecting biomanufacturing facilities can be addressed with the use of new digital technologies. Thus, shift towards smart manufacturing, implementing smart manufacturing is driven the growth of market. Quicker turnaround across all levels of the value chain by digital manufacturing is leads to lowering maintenance costs. This in turn to drive the growth of market. Real-time production visibility made possible by digital technologies offers better information for making important decisions and accelerates innovation. Thus, digital biomanufacturing technology has increasingly use through pharmaceutical and biopharmaceutical industries. Manufacturers are implementing new technologies such as internate of things (IoT), artificial intelligence (AI) and among others to drive the production is strengthen the demand for digital biomanufacturing. Moreover, automation in manufacturing would provide substantial opportunities to overcome many of the challenges faced in commercial success. This in turn to create significant opportunity for market growth in near future

Key features of the study:

  • This report provides an in-depth analysis of the global digital biomanufacturing market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global digital biomanufacturing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMERIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global digital biomanufacturing market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global digital biomanufacturing market

Detailed Segmentation:

  • Global Digital Biomanufacturing Market, By Type:
    • Manufacturing Technologies
    • Analytical and Process Control Technologies
    • Others
  • Global Digital Biomanufacturing Market, By Application:
    • Bioprocess Optimization
    • Biomanufacturing Process Automation and Control
    • Others
  • Global Digital Biomanufacturing Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • 3M*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • ABB
    • Cytiva
    • Siemens
    • immersciobio
    • Sanofi
    • BIOMERIEUX
    • Agilent Technologies, Inc
    • GE Healthcare
    • Culture Biosciences

" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Development
  • Regulatory Scenario
  • PEST Analysis
  • Porter's Analysis
  • Advances in Digital Biomanufacturing
  • Overview of Digital Biomanufacturing

4. Global Digital Biomanufacturing Market - Impact of Coronavirus (Covid-19) Pandemic

  • Government Initiative to Combat Covid-19
  • COVID 19 Epidemiology
  • COVID 19 Impact on Supply Chain

5. Global Digital Biomanufacturing Market, By Type, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Manufacturing Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Analytical and Process Control Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Digital Biomanufacturing Market, By Application, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Bioprocess Optimization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Biomanufacturing Process Automation and Control
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Digital Biomanufacturing Market, By Region, 2017-2030 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

  • Company Profiles
    • 3M
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • ABB
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Cytiva
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Siemens
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • immersciobio
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Sanofi
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • BIOMERIEUX
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Agilent Technologies, Inc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • GE Healthcare
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Culture Biosciences
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact